Preclinical characterization of HBW-012-E, a novel, potent, selective, safe, and orally active KRAS G12D inhibitor with superior pharmacokinetic (PK) properties and anti-tumor efficacy Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Lee, Ning
  • Li, Yingfu
  • Liu, Guanfeng
  • Li, Jiang
  • Ren, Junfeng

publication date

  • June 1, 2024